Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Naga P. Chalasani, MD
Indiana University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Liver Health
Chandler, Arizona, United States
- Arizona Liver Health
Tucson, Arizona, United States
- Arkansas Gastroenterology
North Little Rock, Arkansas, United States
- Inland Empire Clinical Trials, Llc
Rialto, California, United States
- Integrity Clinical Research Llc
Doral, Florida, United States
- Indago Research and Health Center, Inc.
Hialeah, Florida, United States
- Florida Research Institute
Lakewood Rch, Florida, United States
- Advanced Pharma Cr Llc
Miami, Florida, United States
- Med-Care Research
Miami, Florida, United States
- Summit Clinical Research Llc
Athens, Georgia, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- M3 Wake Research Associates
Raleigh, North Carolina, United States
- Centex Studies, Inc.
Houston, Texas, United States
- Liver Specialists of Texas/mt. Olympus Medical Research
Houston, Texas, United States
- American Research Corporation at the Texas Liver Institute
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jan 2020
- Primary completion
- 1 Sept 2022
- Completion
- 1 Sept 2022
- Last update posted
- 25 May 2023
- Registered enrollment
- 205
- Registry id
- NCT04198805
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.